Biography

Dr. Ann Burchell is Research Director at the Department of Family and Community Medicine and Scientist at the MAP Centre for Urban Health Solutions at St. Michael’s Hospital, Toronto. She is a Canada Research Chair in Sexually Transmitted Infection Prevention. She holds degrees in epidemiology from the University of Toronto (MSc) and McGill University (PhD) and has academic appointments as Associate Professor, Department of Family and Community Medicine, Faculty of Medicine, and Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto; Adjunct Professor, Division of Cancer Epidemiology, McGill University; and Adjunct Scientist, Institute for Clinical Evaluative Medicine, Toronto.

Dr. Burchell’s research program focuses on the epidemiology of human immunodeficiency virus (HIV) infection, human papillomavirus (HPV), syphilis, and other sexually transmitted infections (STIs). Its goal is to generate evidence for effective and practical strategies to prevent STIs and STI-related cancers in high-risk populations, including people living with or at risk for HIV.

She has extensive methodological experience in the design and implementation of: observational longitudinal studies with primary and secondary data; sexual behaviour and health-access questionnaires; natural history studies using laboratory markers of infection; and pragmatic randomized trials for HPV prevention and improved screening for syphilis, cervical and anal cancer. She currently holds a Foundation Grant from the Canadian Institutes of Health Research.

Visit the Estimate Lab website.

Recent Publications

  1. MacKinnon, KR, Grewal, R, Tan, DH, Rousseau, R, Maxwell, J, Walmsley, S et al.. Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trial. BMC Health Serv Res. 2021;21 (1):625. doi: 10.1186/s12913-021-06602-1. PubMed PMID:34193138 PubMed Central PMC8243864.
  2. Burchell, AN, Tan, DHS, Grewal, R, MacPherson, PA, Walmsley, S, Anita, R et al.. Routinised Syphilis Screening among Men Living with HIV: A stepped wedge cluster randomised controlled trial. Clin Infect Dis. 2021; :. doi: 10.1093/cid/ciab582. PubMed PMID:34175944 .
  3. Skerritt, L, de Pokomandy, A, O'Brien, N, Sourial, N, Burchell, AN, Bartlett, G et al.. Discussing reproductive goals with healthcare providers among women living with HIV in Canada: the role of provider gender and patient comfort. Sex Reprod Health Matters. 2021;29 (1):1932702. doi: 10.1080/26410397.2021.1932702. PubMed PMID:34165395 PubMed Central PMC8231384.
  4. Tan, DHS, Tavangar, F, Fusca, L, Ross, P, Hull, MW, Grennan, T et al.. Interest in Hypothetical Preexposure Prophylaxis Against Herpes Simplex Virus: A Cross-Sectional Survey. Sex Transm Dis. 2021;48 (8):e105-e108. doi: 10.1097/OLQ.0000000000001342. PubMed PMID:34110756 .
  5. Zhabokritsky, A, Szadkowski, L, Burchell, AN, Cooper, C, Hogg, RS, Hull, M et al.. Immunological and virological response to initial antiretroviral therapy among older people living with HIV in the Canadian Observational Cohort (CANOC). HIV Med. 2021; :. doi: 10.1111/hiv.13125. PubMed PMID:34075683 .
  6. Grewal, R, Deeks, SL, Hart, TA, Cox, J, De Pokomandy, A, Grennan, T et al.. Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019. Vaccine. 2021;39 (28):3756-3766. doi: 10.1016/j.vaccine.2021.05.031. PubMed PMID:34074547 .
  7. Trevisan, A, Wissing, MD, Dagenais, C, Forest, P, Ramanakumar, AV, Burchell, AN et al.. Development and evaluation of a new non-competitive Luminex immunoassay detecting antibodies against human papillomavirus types 6, 11, 16 and 18. J Gen Virol. 2021;102 (5):. doi: 10.1099/jgv.0.001610. PubMed PMID:34043499 .
  8. Mbuagbaw, L, Logie, CH, Thabane, L, Smaill, F, Smieja, M, Burchell, AN et al.. The impact of routine HIV drug resistance testing in Ontario: A controlled interrupted time series study. PLoS One. 2021;16 (4):e0246766. doi: 10.1371/journal.pone.0246766. PubMed PMID:33798201 PubMed Central PMC8018617.
  9. Malagón, T, MacCosham, A, Burchell, AN, El-Zein, M, Tellier, PP, Coutlée, F et al.. Sex- and Type-specific Genital Human Papillomavirus Transmission Rates Between Heterosexual Partners: A Bayesian Reanalysis of the HITCH Cohort. Epidemiology. 2021;32 (3):368-377. doi: 10.1097/EDE.0000000000001324. PubMed PMID:33625158 PubMed Central PMC8012224.
  10. Wang, L, Moqueet, N, Simkin, A, Knight, J, Ma, H, Lachowsky, NJ et al.. Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis. AIDS. 2021;35 (7):1113-1125. doi: 10.1097/QAD.0000000000002826. PubMed PMID:33534205 PubMed Central PMC8183492.
Search PubMed

Affiliations & Other Activities

  • Associate Professor, Dalla Lana School of Public Health, University of Toronto,
  • Associate Professor, Department of Family and Community Medicine, University of Toronto
X